arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

LEMAITRE VASCULAR INC

LMAT
$80.98 ▲ +1.72 (+2.18%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
83
Health
Excellent
Bullish
auto_awesome

Analytical Summary

LEMAITRE VASCULAR INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.9B
Dividend Yield 0.31%
Revenue Growth 9.6%
Op. Margin 29.0%
ROIC 3.7%
FCF / Share $0.70
Trailing P/E 108.0x
Price / Book 4.4x
FCF Yield 0.9%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$70.38M
↑ +9.6%
Net Income Profit after all expenses
$15.68M
↑ +42.4%
Operating Margin Operating profit as % of sales
29.0%
↑ +8.5% 84th
FCF / Share Free cash flow per share
$0.70
↑ +5.5%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
87
Returns
80
Financial Health
85
Cash Quality
78

Dividend History

Dividend / share · sourced from SEC filings
$0.80 Latest / share
+25.0% YoY
+17.2% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters